Pricing Log in Create free account

Caribou Biosciences, Inc. (CRBU) vs MiNK Therapeutics, Inc. (INKT)

Caribou Biosciences, Inc. and MiNK Therapeutics, Inc. are both Biotechnology companies. Caribou Biosciences, Inc. and MiNK Therapeutics, Inc. are of similar size ($50.7M and $49.8M). MiNK Therapeutics, Inc. has the higher net margin (0.00% vs −1,030.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, MiNK Therapeutics, Inc. leads on 6 and Caribou Biosciences, Inc. on 5.

Valuation

Metric CRBU INKT Biotechnology median
P/E n/m n/m 8.50
P/S 4.73 n/m 9.71
P/B 0.48 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.60 n/m 0.64
EV/Sales (6.46) n/m 9.21
Earnings yield (229.79%) (25.50%) (33.15%)
Free cash flow yield (279.78%) (14.61%) (25.50%)

Profitability

Metric CRBU INKT Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (1,090.90%) 0.00% 0.00%
Net margin (1,030.42%) 0.00% 0.00%
Free cash flow margin (1,323.30%) 0.00% 0.00%
Return on equity (78.27%) 57.94% (56.36%)
Return on assets (56.87%) (187.78%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRBU INKT Biotechnology median
Revenue growth (TTM) 10.02% — 6.02%
EPS growth (last fiscal year) 3.64% (2.45%) 30.26%
Revenue growth, 5-year CAGR (2.03%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBU INKT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.49 1.23 4.72
Net debt to EBITDA 0.96 1.07 0.96

Dividend

Metric CRBU INKT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CRBU INKT Biotechnology median
Market cap 49.82m 50.73m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack